Interesting. So Petit already knew about the termination when he wrote that. One has to wonder. Was he just bitter? What was he seeing that amgen didn't care to participate in...

If they bought the company they'd be paying themselves that money. Wouldn't matter.

How is there no response from this friggin' company!?

They've had this knowledge for days.

They never cease to amaze.

That seems awfully childish if so, especially if they believed in the product. If neo was so promising then they would have found a way to work it out. They had very little to lose in the agreement. Something is up. No response from the company either.

Aduro and now Adxs with terminated partnerships.

How much could HOT and NEO together go for?

There is no way this is a good thing. The best investment thesis for this stock was Amgen backing it. They had to of seen something. This was a great deal for them with basically no down side other than what they already lost.

I wonder how blindsided Adxs was by this? It seems like they didn’t see this coming as there is zero response. This is just unbelievable at this point. This was something I never even thought was possible.

I only hope this company is worth more than rosg.

It's back red now.

Speechless

So, could they just sell the whole company now? Idk how re-licensing it would go given what just happened.

Amgen must not have liked what they saw and/or have something that is better. What a total cluster.

What does earnings have to do with anything... Are you looking for an Amgen payment or something?

They burned cash - have added to their accumulated deficit - that's what we'll see.

Nary a tweet from Petit going on 5 months now since he referenced a seeking alpha article. Nor was he on the last call.

I wonder how everyone's feeling behind closed doors at Advaxis HQ...

He already learned his lesson when he bought ADXS shares in June. He's now down over 80% with that generous $25k purchase.

I doubt he ever bought ROSG. He was too smart to do that.

Negative EV, almost 2 decades in business, no "failed" trials. Something is missing.

The NYSE has a 25 million dollar minimum market cap requirement.

The potential r/s and looming share raise could be one reason?

Plus bonuses, plus cheap options, plus RSU's, plus whatever free lunch was in the kitchen last week. The guy certainly doesn't have a position I would envy, but he'll be just fine.

Just like how he ended up just fine at ROSG..

We can all agree on that.

Risk management is a course that a lot of people (including myself) need to take more of.

Always appreciate the posts. Thanks.

As I know you've been a longtime advocate of the stock, you've played this 100x better than most people here I presume. Well done.

So #4. You've cost averaged down to under 1.65$? Bravo!

I don't think most people here are in your boat, hence the anger. They've bought in on far too many dips which were actually sell points.

I'm saying we potentially still have a long ways to go before a buyout, Catt.

Please, share with us again the written law stating how companies don't have to report ownership (13d) of another company if they're in the same line of business...in order to screw shareholders and keep buyout costs down. Sounds great for us adxs ltsh!

And why would you say that? We've had promising data for YEARS....there's no buyout. Look at where we're at.

I supposed if we have multiple CR's from NEO than maybe, but that's beyond wishful thinking.

The company is on its last leg for sure. I'm still hoping for the best though.

What does KB have in his back pocket which makes him still retain close to 80 employees at ADXS?

A mirage to uphold. This thing is like a house of cards ready to tumble (or already has). It was clear when we were burning 80 million a year we had nothing in the "back pocket" either. Time will tell of course.

Yep. Reality hurts. Bought shares at the wrong times. Every buying opportunity was actually a selling opportunity. Sad

Also, think about the pre-split price of these shares at just a fraction of a penny. Nearly 2 decades in business and here we are...

Employees enjoyed their run.

Cat - that's what we've been waiting over a year+ for. Can they deliver anything like that? Are they even capable? Until then the share price absolutely matters (still burning 40-50 mm/yr).

AXAL-Cerv was almost shutdown according to Kenny. We have few options for cash theses days outside of HOT. This company is in a precarious situation with an uncanny ability to not deliver anything meaningful to shareholders. Those are just the facts...

That’s a 12x return. Apply that to advaxis and we’d be staring at just over $5.

The days of double digits are long gone.

180 days from notice, which I belive was on the 18th of Oct.

"Stock price proves nothing other than what people are willing to pay for shares right this second"

And what does that prove? People don't get it, or they see no real value until possibly another dilution or r/s happens? Granted there's no guarantee of any of it, but look at the ADXS track record...

Haha - I have.

We've all been conned is the conclusion he's convinced of.

Come on now, this has nothing to do with the day-to-day movements but the long term trend. Should people on this board be jubilant over a couple green days?

What's getting old is people on this board pretending they know whether other people own or don't own shares. The stock is an utter disgrace right now and nothing has changed. It's dropped over 75% since Ken has taken over - what story does that tell?

Sure. It's all the negative board posters here that have caused the precipitous decline of this stock. Once a promising biotech, it's now a desperate company trying to raise money due to all the negative Nancy's. Done

Oh, and massive manipulation...

No one has a clue what this board or shareholders would approve at this point. The options for adxs to maintain status quo are dwindling and they've already slayed LTSH.

Another r/s for funding?

At this point all bets are off on what could happen, forced or otherwise.

Yes, that's exactly what I thought. I heard Ken say that partnerships could be easier to attain with the changes they're trying to make to the trial. My hope is this was code for XYZ comp. wants these changes, and when completed, they'll partner. One can hope.

I agree with you on the rest as well.

Gotcha. If that's true, then maybe a trial of this design has some positives related to making some reasonable assumptions on efficacy before any potential readouts, while also remaining blind. Thanks.

Interesting, thanks for sharing.

So is it standard practice for cohort reports like this to be sent to the drug company that is funding the trial? I understand how they can deduce meaningful assumptions from it no matter how opaque they might be, as you mentioned below, but I thought they never even got reports like this to begin with... Thanks.

I agree with that. Data is our savior. I'm just trying to make sure we get there before we sell another 50% of the company for a months cash burn while NEO development costs are "entirely" covered...

That's still up for debate. They may know its not failing, at least according to Dew's analysis. I'm still not sure how in a double blinded, placebo controlled study they can surmise much more than that...

My question is what's changed from 5 months ago when Ken announced the wind-down of the trial? If he knew it wasn't failing then, not much could have changed trial wise in that short a timeframe as you're trying to state...

My hope is they have a partner lined up once the new trial setup is approved, and if that's so, then obviously I'm for it. Meanwhile, they continue to tap the markets on atrocious terms while paying for these longshots. NEO data would help a ton, so whats the harm...

Then cut funding and ride NEO to data if that's what needs to be done. Unfortunately they're not and haven't. Instead they've continued to act like they have money coming in which has proven to be utterly false, hence their need to continually tap the capital markets on absolutely abysmal terms.…

NEO deal is the only value these guys have created through their Amgen partnership.

Well said.

The market did their job by providing them 100's of millions and we've seen what they've done with it. The market cut off their funding and now this thing will continue to sink unless they can produce something of value...

Yah. They're in the middle of a buyout process while the stock is idling around 50 cents a share. I wonder how that might work...buyout at $2?

Aduro down big. ADXS down big. LM :/

Well said. I can understand that.

However, I do hope this "smidgen" of rational, based on blended data that the trial is not failing, isn't the main impetus behind continuing the funding of it. Cutting it for cash reasons made sense to me and now that's no longer the case.

I'm still hoping Blue is right in that the reason ADXS is continuing the trial, along with the potential changes, is to accelerate the process of securing a partner who will eventually take it over.

I suppose you combine that with your statement and I guess we could have something.

It was an honest question. I still don't see how Advaxis knows that AIM2CERV is working.